These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2407916)

  • 1. Treatment-related toxicities with Fluosol-DA 20% infusion during radiation in advanced head and neck malignancies.
    Campbell BH; Janjan NA; Byhardt RW; Toohill RJ
    Laryngoscope; 1990 Mar; 100(3):237-9. PubMed ID: 2407916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck.
    Lustig R; McIntosh-Lowe N; Rose C; Haas J; Krasnow S; Spaulding M; Prosnitz L
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1587-93. PubMed ID: 2722598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck.
    Rose C; Lustig R; McIntosh N; Teicher B
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1325-7. PubMed ID: 3759553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
    Dietz A; Nollert J; Maier H; Rudat V; Flentje M
    HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.
    Zajusz A; Maciejewski B; Hliniak A
    Neoplasma; 1995; 42(3):137-40. PubMed ID: 7637824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF; Porter EA; Fischer JJ; Rockwell S
    Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
    Klima A; Szepesi S
    Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma.
    Lustig RA; Rose CM; McIntosh-Lowe NL
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):511-8. PubMed ID: 3179488
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
    Russo G; Haddad R; Posner M; Machtay M
    Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
    Allal AS; Maire D; Becker M; Dulguerov P
    Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.